CFO News

JULY 20, 2025

The CBIC's clarification resolves concerns, particularly for pharmaceutical units, and should apply across industries claiming refunds. A dispute between the govt and corporations operating factories in hilly regions has ended, with companies now eligible for GST refunds based on actual value addition, subject to verification.

Pharmaceutical

CFO News

MAY 6, 2025

India has proposed eliminating tariffs on steel, auto components, and pharmaceuticals for a specific import quantity in trade negotiations with the US. Beyond that threshold, standard duties would apply. This offer aims to expedite a bilateral trade deal expected by fall, prioritizing certain sectors before the end of the US tariff pause.

Pharmaceutical

CFO News

MAY 23, 2025

Sun Pharmaceutical Industries Ltd will invest up to USD 25 million in Pharmazz Inc, increasing its stake to 22.7%. This investment triggers the conversion of a previous agreement. Sun Pharma gains an option to negotiate licensing of Sovateltide for developed markets and already holds exclusive rights for emerging markets.

Pharmaceutical

Future CFO

JULY 20, 2025

Pei Lu Lee, finance director - Malaysia and Singapore at Warner Music Group One particularly meaningful chapter in my journey was during my time in the pharmaceutical industry. I partnered closely with the medical and product teams to bring in new treatments to Malaysia.

Leadership

CFO News

MAY 22, 2025

In the midst of global trade realignments and industrial policy shifts, India is increasingly positioned to function as a "connector country" that can become a key intermediary in sectors such as technology, digital services, and pharmaceuticals, according to the Reserve Bank of India (RBI).

Pharmaceutical

CFO Thought Leader

JANUARY 20, 2025

On this episode of 1-2-3 , Emma Seymour , CFO at Deputy, reveals the behind-the-scenes steps to raising capital from strategic partners and achieving unicorn status. Next, Dev Ahuja , CFO of Novelis , explains how his pharmaceutical background at Novartis fueled disciplined resource allocation and strategic growth in manufacturing.

Pharmaceutical

Barry Ritholtz

APRIL 8, 2025

And valuations have been, you know, with the exception of, of some of the obesity drugs, the pharmaceutical industry has been squashed by, by worries about regulations squashed by the power of the insurance companies, you know, squashed by patent, expire, you know, squashed by a lot, a lot of things.

Mergers and Acquisitions (M&A)

CFO Talks

OCTOBER 28, 2024

Members Spotlight: Professor Ian Kruger At CFO Club Africa, we take pride in sharing the stories and achievements of our members through a dedicated profile series. These profiles spotlight the journeys, expertise, and personal insights of CFOs and finance leaders who are making a real impact in their organizations and the finance industry.

CFO

CFO News

MAY 12, 2025

President Trump's plan to lower US prescription drug prices by aligning them with other countries could impact Indian pharmaceutical companies, which heavily rely on the US market for revenue.

Pharmaceutical

CFO News

APRIL 13, 2025

is preparing to announce sweeping tariffs on pharmaceutical imports within the next two months, according to Commerce Secretary Howard Lutnick. President Donald Trump says the move will push drug companies to manufacture in America. India, which supplies over 45% of U.S. generics, stands to lose big.

Pharmaceutical

Global Finance

MARCH 4, 2025

Since 2016, Anne-Laure Autret-Cornet has been the CFO of OSE Immunotherapeutics, a biotech dedicated to immuno-oncology and immuno-inflammation. Global Finance: What has been your biggest challenge as CFO? And we have ongoing important collaborations with other companies such as Boehringer Ingelheim and Veloxis Pharmaceuticals.

CFO

CFO News

APRIL 30, 2025

British drugmaker GlaxoSmithKline said Wednesday it is "well positioned" to respond to US President Donald Trump's potential tariffs on pharmaceuticals and maintained its 2025 outlook. "The

Pharmaceutical

CFO News

JULY 21, 2025

The CBIC's clarification resolves concerns, particularly for pharmaceutical units, and should apply across industries claiming refunds. The disagreement stemmed from differing interpretations of value addition caps post-GST implementation.

Pharmaceutical

CFO Dive

JULY 9, 2025

Skip to main content CONTINUE TO SITE ➞ Dont miss tomorrows CFO industry news Let CFO Dives free newsletter keep you informed, straight from your inbox. In a survey by the Big Four accounting firm, about 33% CFOs said they believe now is a good time to take on more risk, d own from 60% who expressed the same view in the first quarter.

CFO

CFO News

NOVEMBER 7, 2024

Expectations of increased demand in sectors such as IT, pharmaceuticals, and chemicals, driven by the “China Plus One” policy, may boost investor sentiment. ​In the immediate term, India’s equity markets are likely to react positively to Trump’s victory.

Pharmaceutical

CFO News

JULY 30, 2025

Indian pharmaceutical industry leaders strongly criticize U.S. President Trump's tariff announcement, arguing it will harm the American healthcare system more than India's economy. They emphasize India's crucial role in supplying affordable medicines, particularly generics, to the U.S.,

Pharmaceutical

CFO News

JUNE 27, 2025

Torrent Pharma is in advanced talks with KKR to acquire JB Chemicals and Pharmaceuticals, reviving discussions from last year. The deal involves Torrent acquiring KKR's 47.84% stake and launching an open offer, potentially leading to a Rs 20,734.61 crore buyout.

Pharmaceutical

CFO News

JULY 20, 2025

Shanghai Fosun Pharmaceutical Co. The Chinese parent has diversified investments that range from healthcare to football clubs, asset management, banks, estate, hospitality, fashion and industrials. The conglomerate has a presence across the pharma value chain from manufacturing to diagnostics and medical devices.

Pharmaceutical

CFO News

JUNE 9, 2025

India’s iPhone output has soared, helping exports surpass even pharmaceuticals. Apple and Foxconn are deepening their India bet with a $1.5 billion investment, despite Donald Trump’s warning against building there. But shifting from China isn’t easy.

Pharmaceutical

CFO News

JULY 15, 2025

US President Trump had earlier suggested pharmaceutical tariffs could reach 200% after a year, incentivizing domestic manufacturing. On Tuesday, he said that an agreement with India was among the most likely.

Pharmaceutical

CFO News

AUGUST 5, 2025

President Donald Trump said new tariffs on imported pharmaceuticals will start small but could rise to 250% within 18 months to boost domestic production. He also plans to announce fresh duties on foreign semiconductors, aiming to reduce U.S. reliance on overseas supply chains.

Pharmaceutical

CFO News

JUNE 30, 2025

Sectors like textiles and pharmaceuticals could benefit. Both countries have agreed on important points. However, the benefits for India are not yet clear. Avoiding a 26% tariff is the only visible gain so far.

Pharmaceutical

CFO News

JUNE 26, 2025

The US seeks lower tariffs on farm exports, but India is cautious due to its large rural workforce and concerns over competition in sectors like pharmaceuticals. A keenly-eyed India-US interim trade arrangement hangs in balance due to tariff disputes on steel, auto parts, and agriculture, ahead of President Trump's July 9 deadline.

Pharmaceutical

CFO Dive

APRIL 25, 2023

The biopharmaceutical company is parting ways with former CFO Leo Greenstein, who started at his post back in 2020.

Pharmaceutical

CFO Dive

JANUARY 8, 2024

Tying the prices it charges for medicines to those charged by pharmaceutical companies will put the healthcare giant’s pharmacy business on a more sustainable footing, executives said.

Pharmaceutical

CFO News

MARCH 18, 2025

ENTOD Pharmaceuticals has appointed Balasubramanian K Pillai as its new CFO. Pillai, a Chartered Accountant with over 26 years of diverse experience, aims to enhance financial strategies and drive sustainable growth.

Pharmaceutical

CFO

APRIL 21, 2022

“If we tell you something, it’s because we believe it, and we’re neither sandbaggers nor are we going to lead with our chin and put out outrageous goals,” said Anthony Doyle, CFO of BioCryst Pharmaceuticals, when asked to describe how the publicly held biotech has established credibility by executing on projections.

CFO

CFO News Room

JANUARY 21, 2023

” Eli Lilly — Shares of the pharmaceutical company slumped more than 1% in premarket after the U.S. Regeneron Pharmaceuticals — The pharmaceutical giant gained 1% in the premarket after being upgraded to overweight from neutral by JPMorgan. The firm also announced that co-CEO Reed Hastings would step down from the role.

Pharmaceutical

CFO News

FEBRUARY 13, 2023

"We are in the process of identifying seven centres of excellence (CoE) which will undertake research in moonshot areas," N Yuvaraj, joint secretary, department of pharmaceuticals, to ET.

Pharmaceutical

Future CFO

JANUARY 17, 2022

Hong Kong-listed clinical stage biopharmaceutical firm Transcenta Holding Limited announces the appointment of Daniel Weng as the company's CFO. Prior to Transcenta, he served as the vice president and Head of finance at Hong Kong-listed CStone Pharmaceuticals.

CFO

CFO News Room

DECEMBER 31, 2022

The DEA said in December that it wouldn’t allow any increase in 2023 production of pharmaceutical ingredients that go into Adderall and other stimulants used to treat ADHD. While the letter doesn’t cite specific companies, it reflects the DEA’s concerns about marketing efforts for ADHD treatment by telehealth companies such as Cerebral Inc.

Pharmaceutical

PYMNTS

SEPTEMBER 24, 2020

The September CFO Guide To Digitizing B2B Payments explores how corporate buyers are streamlining their B2B transactions with digital payments and supplier onboarding tools. The CFO Guide To Digitizing B2B Payments , a collaboration between PYMNTS and Comdata , examines how companies are upgrading to digital vendor onboarding and payments.

Accounts Payable

Future CFO

NOVEMBER 22, 2022

Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccines and immunotherapies, announced recently the appointment of Mark Lo Chun Bun as CFO of the Group. More CFO appointment news The post Hong Kong-based Immuno Cure BioTech names new CFO appeared first on FutureCFO.

CFO

CFO News Room

DECEMBER 28, 2022

Kala Pharmaceuticals — The biopharmaceutical company surged more than 200% following the Food and Drug Administration’s acceptance of an investigational new drug application for its potential treatment for persistent corneal epithelial defect. The firm gave the stock a price target of $29, which presents an upside of 75.4%

Entertainment

The Finance Weekly

MAY 4, 2023

Now, more than ever, the decisions made by the CFO are likely to affect the performance of the entire organization. In this article, we have compiled a list of some of the CFO moves that took place in April. CFO Pros on the Move April 2023 Jiajia Wu | Hyzon Motors , Jiajia Wu has been appointed as the interim CFO at Hyzon Motors.

CFO

CFO Talks

AUGUST 15, 2024

Futuristic Finance: Strategic Thinking for Tomorrow’s CFO In an era where rapid technological advancements and global economic shifts are the norm, Chief Financial Officers (CFOs) are not just financial stewards but strategic visionaries. Developing a Strategic Mindset Tomorrow’s CFO must think like a strategist.

CFO

CFO Thought Leader

JULY 30, 2023

Thus it was for Erin Colgan, who in July 2020—after having invested 9 years within the finance rank-and-file of pharma giant Vertex Pharmaceuticals and 8 years with PWC—opted to become the 20th employee of a promising biotech start-up. Colgan observes: “You can’t make those types of decisions ‘later.’

Leadership